Search for: "Pfizer Pharmaceutic, Inc." Results 41 - 60 of 667
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
6 Nov 2020, 7:16 am by Dennis Crouch
” On the facts here: Mylan Pharmaceuticals Inc. [read post]
17 Sep 2020, 4:55 am by Bob Ambrogi
Although that sentence never identified Pfizer as a pharmaceutical company, Parallel Search understood to deliver cases related to the pharma industry, and it also knew to deliver cases related to an FLSA exemption for outside sales people. [read post]
10 Sep 2020, 10:24 am by Shannon Hill
Bristol-Myers Squibb Co. and Pfizer Inc. filed multiple lawsuits in advance of this regulatory approval in an attempt to block entry of the generic drugs on the market and preserve Eliquis’s significant position in the pharmaceutical market. [read post]
7 Aug 2020, 9:15 am by Gregory B. Williams
A copy of the Opinion is attached. [1] Plaintiffs, Bristol-Myers Squibb Company and Pfizer Inc., had originally filed the action against at least twenty-five (25) defendant pharmaceutical companies. [read post]
28 Jun 2020, 7:52 am by Dan Bressler
’s $3.6 billion acquisition of King Pharmaceuticals Inc. in 2010. [read post]
7 May 2020, 11:51 am by Marina Chafa
Just this week, Pfizer, Inc. announced that it had administered the first round of its experimental coronavirus vaccines on patients in the U.S. [read post]
17 Mar 2020, 1:32 pm by Noble McIntyre
Twelve Lots of CHANTIX® (Varenicline) Tablets have been recalled by Pfizer due to N-Nitroso Varenicline content above ADI level. [read post]
3 Mar 2020, 4:00 am by Alan Macek
In Novartis Pharmaceuticals Canada Inc. v. [read post]
18 Feb 2020, 4:00 am by Martin Kratz
Pfizer Canada ULC, 2020 FC 1, at para. 42. [3] See Sections 27(3)(b) and 28.3 of the Patent Act, RSC 1985, c P-4 [4] Burton Parsons Chemicals, Inc v Hewlett-Packard (Canada) Ltd, [1976] 1 SCR 555 at 563 [5] Apotex Inc v Sanofi-Synthelabo Canada Inc, 2008 SCC 61 at paragraph 37, [2008] 3 SCR 265; see also Bell Helicopter Textron Canada Limitée v Eurocopter, société par actions simplifiée, 2013 FCA 219 at paragraph 65; Mylan… [read post]
23 Jan 2020, 10:37 pm by Schachtman
The phosphodiesterases 5 inhibitor medications (PDE5i) seem to arouse the litigation propensities of the lawsuit industry. [read post]